Peritoneal cells were harvested by lavage from noninjected mice and from mice injected intraperitoneally 4 d earlier with either 5 mg of aggregated IgG, HSA-anti-HSA complexes containing 5 mg of HSA, or a control preparation. Macrophages were purified by glass adherence and were cultivated in medium at a concentration of 4 x 10 `4 per coverslip on 13-mm diam, PLL-coated glass coverslips in 35-ram petri dishes or 24-well tissue culture clusters (Costar; Bellco Glass, Inc., Vineland, N J).
C5-deficient mouse serum was obtained from 20-30-g female, C5-deficient AKR mice (The Jackson Laboratory, Bar Harbor, ME). It was adsorbed twice at 4°C for 15 rain with 20% sheep E before being frozen in small aliquots at -70°C, and was thawed on ice just before use as a complement source.
Preparation of Immobilized Immune Complexes.
Immobilized immune complexes were fixed onto 13-mm glass coverslips as previously described (11, 13) .
Preparation of Lymphokine.
Culture supernatants containing the lymphokine that activates mouse peritoneal macrophages' C3 receptors for phagocytosis were prepared and used as previously described (7) .
Assessment of Phagocytosis via Macrophages' C3 Receptors and Fc Receptors.
After a 1 h incubation, macrophage monolayers were washed, overlaid with fresh medium, and incubated for an additional 3 h at 37 ° C. Some cells were then overlaid with lymphokinecontaining supernatant, others with fresh medium. 0.2 ml of 0.5% E, EIgG, EIgM, or EIgMC were added to each 35-mm petri dish, and cultures were incubated for 30 min at 37°C. Cultures were then washed and fixed with glutaraidehyde, and E attachment and ingestion were scored by phase contrast microscopy. Because in all of these assays all macrophages avidly bound EIgMC and none bound or ingested either E or EIgM, individual attachment and ingestion data obtained using these particles are not reported.
Assessment of Macrophage C3 Receptor Mobility.
Freshly harvested macrophages were plated on coverslips coated with C3-containing immune complexes. After a 1 h incubation to allow macrophages to adhere, coverslips were washed and were overlaid with lymphokine-containing supernatant or fresh medium. After a 15 min incubation at 37 ° C, cultures were washed and covered with 1 ml of fresh medium. 0.1 ml of 0.5% EIgMC was added to each well and cultures were incubated for 1 h at 37°C, washed, and fixed with glutaraldehyde. E attachment was scored by phase contrast microscopy.
In this assay, C3 receptors that are mobile become trapped on the immobilized immune complexes when they diffuse randomly from the nonadherent to the adherent macrophage surface; rnacrophages with mobile receptors therefore lose the ability to bind EIgMC. In contrast, C3 receptors that are immobile are unable to diffuse within the macrophage plasma membrane and remain in place even when macrophages are plated on immobilized immune complexes; these macrophages therefore retain the ability to bind EIgMC.
Presentation of Results.
Unless otherwise indicated, each result presented is the average of at least three separate determinations, each performed in duplicate. The attachment index and the phagocytic index are the number of E attached or ingested by 100 macrophages and were obtained by multiplying the percent of macrophages that had attached or ingested any E by the average number of E attached or ingested per macrophage. Each result is presented as mean + SEM.
Results
Outbred Swiss mice were injected intraperitoneally with either soluble immune complexes or aggregated IgG. 4 d later, peritoneal macrophages were harvested, plated as described in Materials and Methods, and assayed for their ability to phagocytize via their Fc receptors and C3 receptors. Macrophages from mice that had received no injection avidly ingested EIgG but failed to ingest EIgMC (Table I , line 1), as expected. Macrophages from mice injected with either nonaggregated lgG or "sham" immune complexes composed of HSA and nonimmune rabbit serum behaved identically to those from mice that had received no injections (data not shown). In contrast, macrophages from mice that had been injected with either immune complexes or aggregates ingested EIgG poorly but were able to ingest EIgMC (Table I , lines 2 and 3). The defective uptake of EIgG by macrophages from mice that had received injections of immune complexes appeared to be due to blockade of the cells' Fc receptors by the complexes because treatment with 1 m g/ml of trypsin for 30 rain at 37 °C, a procedure that releases immune complexes from cells' Fc receptors (14) , enabled macrophages to phagocytize EIgG efficiently (Table II) .
To determine whether or not T lymphocytes were required for in vivo activation of macrophages' C3 receptors, we performed experiments identical to those reported in Table I , lines 1-3, using athymic mice and their euthymic, congenic littermates. The macrophages of the euthymic littermates behaved identically to those of outbred Swiss mice (Table I , lines 4-6); however, macrophages from athymic mice were unable to phagocytize EIgMC (Table I , lines 7-9). Macrophages from athymic mice could, after immune complex uptake, signal T lymphocytes from other mice to elaborate the lymphokine (data not shown), and these animals' macrophages could respond to the lymphokine in vitro (Table  III) , indicating that the failure of their C3 receptors to be activated in vivo was not due to an intrinsic defect in the macrophages' ability to participate in the generation of the lymphokine or in their ability to respond to it, but rather was due to the absence of T lymphocytes. Thus, activation of macrophages' C3 receptors in vivo requires T lymphocytes.
The C3 receptors of mouse peritoneal macrophages are normally immobilized and unable to diffuse within the cell's plasma membrane (11, 13) . Activation of macrophages' C3 receptors for phagocytosis by the lymphokine in vitro is accompanied by the acquisition of receptor mobility (11) . We found that receptor mobility accompanied in vivo activation of macrophages' C3 receptors as well (Table IV) . C3 receptors of macrophages from all mice were intrinsically immobile (Table IV , lines 1, 4, and 7) and unable to promote phagocytosis (Table  I , lines 1, 4, and 7). C3 receptors of macrophages from euthymic mice that had received intraperitoneal injections of immune complexes or aggregates were both mobile (Table IV, lines 2, 3 , 5, and 6) and able to promote phagocytosis (Table I, lines 2, 3 , 5, and 6). In contrast, C3 receptors of macrophages from athymic mice that had received injections of immune complexes or aggregates were both immobile (Table IV, lines 8 and 9 ) and unable to promote phagocytosis (Table I, lines 8 and 9 ). These results support our hypothesis that the lymphokine activates macrophages' C3 receptors for phagocytosis by freeing the receptors from their anchors and allowing them lateral mobility.
Discussion In the present experiments we created an immunologicaily mediated inflammatory focus in the mouse peritoneal cavity by injecting either soluble immune complexes or aggregated IgG. We found that macrophages present at this inflammatory site were markedly impaired in their ability to ingest via their Fc receptors but had acquired the ability to phagocytize via their C3 receptors.
We have previously (9, 10) found that macrophages' Fc receptors could be blocked in vitro by microgram quantities of immune complexes. Our finding that macrophages obtained from an in vivo milieu containing immune complexes were defective in their ability to phagocytize IgG-coated particles strongly suggests that immune complexes can block the cells' Fc receptors in vivo as well. Receptor blockade was apparently achieved by occupancy of receptors by the complexes rather than by receptor internalization or destruction, because trypsin treatment promptly restored Fc receptor activity. The apparent ease with which macrophages' Fc receptors can be blocked by immune complexes in vivo strongly suggests that these receptors may be unable to promote uptake of opsonized microorganisms at sites of infection in an immune host.
Macrophages' C3 receptors are not normally phagocytic (1-10). We have previously found (7-12) that a unique lymphokine can activate these receptors so that they can promote phagocytosis. For T lymphocytes to elaborate the lymphokine, they must receive a signal from macrophages that have ingested IgG-containing immune complexes (7). We therefore determined the ability to phagocytize via their C3 receptors of macrophages obtained from an inflammatory focus containing macrophages, immune complexes, and T lymphocytes. These macrophages were able to pbagocytize C3-coated particles, indicating that their C3 receptors had been activated in vivo. The requirement for both T lymphocytes and immune complexes for activation of macrophages' C3 receptors in vivo is identical to the requirements for activation of macrophages' C3 receptors in vitro, suggesting that the mechanisms we have identified for activation of these receptors in vitro are the same mechanisms by which the receptors are activated for phagocytosis in vivo.
Our findings support the following model for the ingestion of opsonized microorganisms in vivo. Invading microorganisms become coated with both IgG and C3 in the immune host. Many pathogens shed antigens that become bound by host antibody, and soluble immune complexes composed of shed microbial antigen and host antibody are probably plentiful at sites of infection. Macrophages' Fc receptors are easily blocked when they ingest the immune complex debris, thereby impairing these receptors' ability to clear IgG-coated microorganisms. Uptake of these soluble complexes triggers macrophages to signal T lymphocytes to elaborate the lymphokine that activates macrophages' C3 receptors for phagocytosis. Unlike their Fc receptors, macrophages' C3 receptors are not very susceptible to blockade by immune complexes, even when the complexes contain complement components (9). These receptors are therefore able to promote phagocytosis of the opsonized microorganisms. Note that our model proposes a most unusual type of receptor cooperation in which ingestion of immune complex debris by macrophages' Fc receptors initiates a series of cellular and molecular events culminating in activation of the cells' C3 receptors and that it is the macrophages' C3 receptors, not their Fc receptors, that are primarily responsible for promoting phagocytosis of opsonized microorganisms.
Summary
We assessed the effects of exposure to immune complexes in vivo on macrophages' Fc receptor function and C3 receptor function. Peritoneal macrophages from mice injected intraperitoneally with immune complexes were markedly impaired in their ability to phagocytize via their Fc receptors but had acquired the ability to phagocytize via their C3 receptors. In vivo activation of macrophages' C3 receptors for phagocytosis required T lymphocytes, because macrophages from athymic mice could not be activated by injection of immune complexes.
The requirement for both T lymphocytes and immune complexes for activation of macrophages' C3 receptors in vivo is identical to the requirements for activation of macrophages' C3 receptors in vitro, suggesting that the mechanisms we have identified for activation of these receptors in vitro are the same mechanisms by which the receptors are activated for phagocytosis in vivo. The susceptibility of macrophages' Fc receptors to blockade by immune complexes and the activation of their C3 receptors for phagocytosis in a milieu containing immune complexes suggest that it may be macrophages' C3 receptors, not their Fc receptors, that are primarily responsible for promoting phagocytosis of opsonized microorganisms in immune hosts.
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